Huanghai Medicine (00013) will announce the latest data of several studies on independently developed compounds at the 2025 World Lung Cancer Congress and the 2025 Annual Meeting of the Chinese Clinical Oncology Society.

Zhijing Financial APP news, Hutchison China MediTech (00013) announced that at the 2025 World Lung Cancer Conference (WCLC) to be held in Barcelona, Spain from September 6 to 9, 2025, as well as at the Chinese Society of Clinical Oncology (CSCO) 2025 annual meeting to be held in Jinan, China from September 10 to 14, will announce the latest and updated data from several studies on compounds independently developed by Hutchison China MediTech.